T2 Biosystems (TTOO) Competitors $0.08 +0.06 (+344.44%) As of 08/1/2025 01:08 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TTOO vs. LGMK, BBLG, AVGR, NUWE, DYNT, BIOL, SONX, IONM, HSDT, and SDCCQShould you be buying T2 Biosystems stock or one of its competitors? The main competitors of T2 Biosystems include LogicMark (LGMK), Bone Biologics (BBLG), Avinger (AVGR), Nuwellis (NUWE), Dynatronics (DYNT), BIOLASE (BIOL), Sonendo (SONX), Assure (IONM), Helius Medical Technologies (HSDT), and SmileDirectClub (SDCCQ). These companies are all part of the "medical equipment" industry. T2 Biosystems vs. Its Competitors LogicMark Bone Biologics Avinger Nuwellis Dynatronics BIOLASE Sonendo Assure Helius Medical Technologies SmileDirectClub T2 Biosystems (NASDAQ:TTOO) and LogicMark (NASDAQ:LGMK) are both small-cap medical equipment companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, media sentiment, valuation, profitability and risk. Is TTOO or LGMK more profitable? LogicMark has a net margin of -141.96% compared to T2 Biosystems' net margin of -563.16%. T2 Biosystems' return on equity of 0.00% beat LogicMark's return on equity.Company Net Margins Return on Equity Return on Assets T2 Biosystems-563.16% N/A -174.06% LogicMark -141.96%-124.91%-92.05% Which has more risk and volatility, TTOO or LGMK? T2 Biosystems has a beta of 0.43, meaning that its stock price is 57% less volatile than the S&P 500. Comparatively, LogicMark has a beta of 1.48, meaning that its stock price is 48% more volatile than the S&P 500. Does the media favor TTOO or LGMK? In the previous week, T2 Biosystems and T2 Biosystems both had 1 articles in the media. LogicMark's average media sentiment score of 1.99 beat T2 Biosystems' score of -1.00 indicating that LogicMark is being referred to more favorably in the news media. Company Overall Sentiment T2 Biosystems Negative LogicMark Very Positive Do insiders and institutionals believe in TTOO or LGMK? 23.2% of T2 Biosystems shares are held by institutional investors. Comparatively, 7.9% of LogicMark shares are held by institutional investors. 0.0% of T2 Biosystems shares are held by company insiders. Comparatively, 2.2% of LogicMark shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has preferable valuation and earnings, TTOO or LGMK? LogicMark has higher revenue and earnings than T2 Biosystems. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioT2 Biosystems$7.68M0.22-$50.08MN/AN/ALogicMark$9.88M0.31-$14.55M-$223.500.00 SummaryLogicMark beats T2 Biosystems on 8 of the 10 factors compared between the two stocks. Get T2 Biosystems News Delivered to You Automatically Sign up to receive the latest news and ratings for TTOO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TTOO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TTOO vs. The Competition Export to ExcelMetricT2 BiosystemsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.68M$65.78M$5.49B$9.52BDividend YieldN/AN/A4.73%4.09%P/E RatioN/A6.2128.7823.81Price / Sales0.22109.49372.2066.04Price / CashN/A18.4135.4557.96Price / Book-0.017.368.275.54Net Income-$50.08M-$25.86M$3.25B$259.28M7 Day PerformanceN/A-5.86%-3.70%-4.64%1 Month PerformanceN/A3.71%4.34%4.41%1 Year PerformanceN/A47.43%25.90%17.95% T2 Biosystems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TTOOT2 BiosystemsN/A$0.08+344.4%N/A-98.4%$1.68M$7.68M0.00180Negative NewsShort Interest ↑Gap DownLGMKLogicMark0.6819 of 5 stars$0.00flatN/A-100.0%$1.96M$9.88M0.0020Gap DownBBLGBone Biologics0.8009 of 5 stars$2.99-1.0%N/A-83.3%$1.65MN/A0.002Positive NewsUpcoming EarningsAnalyst UpgradeAVGRAvingerN/A$0.47flatN/AN/A$1.57M$7.65M-0.0470Upcoming EarningsNUWENuwellis1.9172 of 5 stars$11.29-6.8%$714.00+6,224.2%-92.1%$1.26M$8.74M-0.0170Short Interest ↑Gap DownDYNTDynatronicsN/A$0.09+0.1%N/A-63.6%$1.19M$33.60M-0.11200Gap UpBIOLBIOLASE0.9473 of 5 starsN/A$1.20+∞N/A$581K$48.83M0.00160Upcoming EarningsGap UpSONXSonendoN/A$1.15flatN/A-71.1%$493K$44.40M-0.02250Upcoming EarningsIONMAssureN/A$0.05flatN/AN/A$150K$149K0.00130HSDTHelius Medical Technologies0.2273 of 5 stars$8.61+5.6%N/A-98.8%$110K$520K0.0030Short Interest ↑SDCCQSmileDirectClubN/AN/AN/AN/A$40K$470.74M0.002,700 Related Companies and Tools Related Companies LogicMark Competitors Bone Biologics Competitors Avinger Competitors Nuwellis Competitors Dynatronics Competitors BIOLASE Competitors Sonendo Competitors Assure Competitors Helius Medical Technologies Competitors SmileDirectClub Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TTOO) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding T2 Biosystems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share T2 Biosystems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
